Massachusetts manufacturers respond to COVID-19

The Manufacturing Emergency Response Team (M-ERT) is a coordinated response by the Baker-Polito Administration and leading academic and industry stakeholders to support the Commonwealth’s manufacturers in their efforts to produce...

Read More

FDA and Health Canada approve Thermedical’s Degassed Saline to help reduce risk of stroke

Health Canada and the U.S. Food & Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied...

Read More

Akili announces FDA clearance of EndeavorRx™ for children with ADHD

Akili Interactive announced this week that the FDA has granted clearance for the company’s EndeavorRx as a prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). Delivered through a captivating video...

Read More

Damon Cox Named New Interim President and CEO of the MLSC

The Massachusetts Life Sciences Center (MLSC), with support from the Executive Office of Housing and Economic Development (EOHED), continues a robust search process for a permanent President and Chief Executive...

Read More

Moderna advances late-stage development of its vaccine against COVID-19

Moderna, Inc. announced progress on late-stage development of mRNA-1273, the company’s mRNA vaccine candidate against COVID-19. Moderna has finalized the Phase 3 study protocol based on feedback from the U.S....

Read More

MIT plays key role in statewide effort to produce PPE

Across the Massachusetts Emergency Response Team (M-ERT) operations, MIT students, faculty, staff, and alumni can be found lending their support to the efforts. In some cases, community members are working...

Read More

A stronger life sciences ecosystem is a diverse one

Our Strength Comes from Collective Commitment to the Principles of Diversity As we continue to listen, learn, reflect, and work to combat racism and inequality in our society, we remain...

Read More

Intravacc and Versatope Sign Research Service Agreement to Develop Universal Influenza Vaccine Based on OMV technology

Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and bacterial  vaccines and Versatope, a U.S. biotechnology company developing vaccines...

Read More